Continuous GLUCOse Monitoring System Compared to Fingerstick Glucose Monitoring in Surgical Wards to Evaluate Glucose Control and Patient Experience

What this Trial Is About

Researchers are evaluating a continuous glucose monitoring system (CGMS) compared to traditional fingerstick blood glucose monitoring in adult patients hospitalized in general surgical wards who require regular blood sugar checks due to risks of low or high glucose levels. The study aims to assess if CGMS provides better glucose management, reduces complications, improves patient and nursing staff experiences, and shortens hospital stays. The trial also examines the accuracy of glucose readings from CGMS versus fingerstick tests and blood samples. Participants will be monitored using either the standard fingerstick capillary glucose method or the CGMS device, with measurements taken by surgical ward nurses according to a set schedule. The CGMS sensor is inserted just under the skin on the upper arm and scanned regularly. The study includes three periods: standard fingerstick monitoring, CGMS monitoring, and a blinded sensor period where CGMS data are collected but not shared with patients or nurses. Diabetes nurses oversee treatment decisions based on the glucose monitoring method used. During the study, participants will undergo glucose level measurements, insulin dose tracking, and complication monitoring throughout their hospital stay, which can last up to 30 days. Patient satisfaction and nursing workload related to glucose monitoring will be evaluated, along with the accuracy of CGMS readings compared to standard methods. Follow-up continues for up to three months after discharge to assess longer-term glucose control and patient experience.

Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring